Four Swiss-based companies will received state funding to develop a range of new drugs to treat coronavirus, which are expected to be available by the end of 2022.
This content was published on
1 minute
swissinfo.ch/dos
Português
pt
Governo suíço financia quatro novos medicamentos contra a Covid
The contracts were signed in the context of the Federal Funding Programme for Covid-19 Medicines, run by the Federal Office for Public Health (FOPH) and the Swiss Innovation Agency Innosuisse, the government said on MondayExternal link.
The total value of the four deals is CHF27 million ($29.2 million).
The projects aim to treat a range of the symptoms caused by a Covid-19 infection and to mitigate the length and severity of illness.
Two of the drugs are monoclonal antibody treatments: one for the neuropsychiatric symptoms in sufferers of long Covid, and the other for use on patients at risk of a severe course of Covid-19. A third project is developing an oral pulmonary vasodilator which makers hope will prevent respiratory failure and reduce the need for artificial ventilation.
A final project is an antiviral and anti-inflammatory to treat “all severities of Covid-19”.
Switzerland will enjoy “certain benefits” in return for its investment, the government stated. This includes having a first option on purchases of the drugs.
The government’s medical procurement capabilities to tackle the coronavirus pandemic come under the remit of the Covid-19 law, approved for a second time by voters in a nationwide referendum two weeks ago.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Swiss army identifies gaps in civil aircraft collision warning system
This content was published on
The Cyber-Defence Campus of the Swiss defence ministry has found two vulnerabilities in the collision warning system for civil aviation.
Swiss parents rely on savings accounts for their children instead of investment funds
This content was published on
According to the survey, over 60% of parents start saving in the first year of life, and around 10% even before the child is born.
Half the Swiss army’s M113 armoured vehicles rehabilitated
This content was published on
Half of the Swiss army's 248 M113 grenadier armoured vehicles are back on the road after being temporarily decommisioned.
Voters in Zurich reject pay rise for local politicians
This content was published on
Local parliamentarians in Zurich will not receive a pay hike after 53.2% of voters in the city came out against the plan on Sunday.
Minimum wage narrowly rejected in canton Basel Country
This content was published on
The Unia trade union initiative had called for a minimum wage of CHF22 ($24.20) per hour for all employees working in the canton.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
It’s not all about age: why Covid hits some people harder than others
This content was published on
New insights: two studies involving Swiss scientists suggest genes and blood sugar levels play a crucial role in the course of Covid-19.
This content was published on
Should we be afraid of virus variants? Will vaccines be effective against new virus forms? Genomic epidemiologist Emma Hodcroft offers some insight.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.